Skip to main content
GRM Overseas Ltd. logo

GRM Overseas Ltd. — Investor Relations & Filings

Ticker · GRMOVER ISIN · INE192H01020 LEI · 335800VQ944C182JYY40 BSE.NS Manufacturing
Open in API
Filings indexed 953 across all filing types
Latest filing 2025-05-22 Board/Management Inform…
Country IN India
Listing BSE.NS GRMOVER

About GRM Overseas Ltd.

https://www.grmrice.com

GRM Overseas Ltd. specializes in the processing, milling, and marketing of premium food products, with a primary focus on high-quality Basmati rice. The company operates an integrated supply chain and utilizes advanced milling technology to produce a diverse range of rice varieties under established brands such as 10:10, Himalaya River, and Tanoush. Beyond its core rice business, the organization has expanded its portfolio into the fast-moving consumer goods (FMCG) sector, offering products including spices and specialized flour. The company maintains a significant international footprint, distributing its products to over 30 countries across the Middle East, Europe, and North America. Its operations emphasize quality control and value-added processing to cater to both domestic and global consumer markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for May 28, 2025. The purpose of the meeting is to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. The document also mentions the closure of the trading window in compliance with insider trading regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a board meeting and the intention to approve financial results, not the results or report itself. Therefore, it is best classified as a Board/Management Information filing, which covers announcements related to board meetings and management decisions.
2025-05-22 English
GRM Overseas Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings
2025-05-22 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended March 31, 2025' and references Regulation 32(6) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It is issued by CARE Ratings Limited as the Monitoring Agency for the utilization of proceeds from a Preferential Issue of Convertible Warrants. The content includes detailed monitoring of fund utilization against the objects of the issue, certifications from Chartered Accountants, and comments from the Monitoring Agency and Board of Directors. The document is about monitoring the use of capital raised through a preferential issue and is a regulatory compliance report rather than a financial statement or earnings release. It is not an announcement of a report but the report itself, with substantive financial and compliance data. This fits the category of Capital/Financing Update (CAP), as it relates to monitoring the use of capital raised and compliance with capital raising regulations.
2025-05-13 English
Monitoring Agency Report for the Quarter ended March 31, 2025
Regulatory Filings
2025-05-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (Bombay Stock Exchange and National Stock Exchange) regarding compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically references Regulation 32(1) and a SEBI circular about the statement of deviation or variation in the use of proceeds from funds raised through a Preferential Issue of Convertible Warrants. The document confirms that there is no deviation or variation in the use of funds for the quarter ended March 31, 2025, and includes a detailed statement of deviation or variation in the prescribed format. This type of filing is a regulatory compliance disclosure related to capital raising and fund utilization, not a full financial report or earnings release. It is not an announcement of a report publication but a regulatory filing itself. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-05-13 English
Statement of Deviation or Variation for the Quarter ended March 31, 2025
Regulatory Filings
2025-05-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.